Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Market Wire News App

BAYZF Articles Bayer AG Registered Shares

home / stock / bayzf / bayzf articles

BAYZF BAYZF Quote BAYZF Short BAYZF News BAYZF Articles BAYZF Message Board

Articles | Bayer AG Registered Shares (OTCMKTS:BAYZF)

  • German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks | Benzinga

    Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a seri...

    • November 24, 2023 05:48:26 pm
    • |
    • Benzinga
    • |
      • BAYZF Stock
      • BAYZF Quote
      • BAYZF Short
      • BAYZF News
      • BAYZF Articles
      • BAYZF Message Board
  • Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence | Benzinga

    Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study early after asundexian showed inferiority to&nb...

    • November 20, 2023 07:58:20 pm
    • |
    • Benzinga
    • |
      • BAYZF Stock
      • BAYZF Quote
      • BAYZF Short
      • BAYZF News
      • BAYZF Articles
      • BAYZF Message Board
  • Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details | Benzinga

    Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study investigating asundexian compared to apixaban (a direct oral...

    • November 20, 2023 06:34:49 pm
    • |
    • Benzinga
    • |
      • BAYZF Stock
      • BAYZF Quote
      • BAYZF Short
      • BAYZF News
      • BAYZF Articles
      • BAYZF Message Board
  • Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss | Benzinga

    Bayer AG (OTC: BAYRY) (OTC: BAYZF) CEO Bill Anderson announced plans to streamline its operations by cutting back on manag...

    • November 08, 2023 04:15:30 pm
    • |
    • Benzinga
    • |
      • BAYZF Stock
      • BAYZF Quote
      • BAYZF Short
      • BAYZF News
      • BAYZF Articles
      • BAYZF Message Board
  • Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss | Benzinga

    Bayer AG (OTC: BAYRY) (OTC: BAYZF) faces another legal setback as a California jury has ruled in favor of a plaintiff who claimed th...

    • November 01, 2023 05:31:40 pm
    • |
    • Benzinga
    • |
      • BAYZF Stock
      • BAYZF Quote
      • BAYZF Short
      • BAYZF News
      • BAYZF Articles
      • BAYZF Message Board
  • From Years to Months: How AI is Shaping the Landscape of Clinical Trials | Benzinga

    Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially ...

    • September 22, 2023 11:49:07 am
    • |
    • Benzinga
    • |
      • BAYZF Stock
      • BAYZF Quote
      • BAYZF Short
      • BAYZF News
      • BAYZF Articles
      • BAYZF Message Board
  • Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories | Benzinga

    Reuters Walmart Settles Lawsuit Regarding Allegations Of Light-Bulb Patent Infringement Walmart Inc (NYSE: WMT) has reportedly resolved the U...

    • August 28, 2023 02:37:08 pm
    • |
    • Benzinga
    • |
      • BAYZF Stock
      • BAYZF Quote
      • BAYZF Short
      • BAYZF News
      • BAYZF Articles
      • BAYZF Message Board
Stock Information
Get BAYZF Alerts

News, Short Squeeze, Breakout and More Instantly...

Bayer AG Registered Shares Company Name:

BAYZF Stock Symbol:

OTCMKTS Market:

Ad

Market Wire News App
RECENT BAYZF NEWS
  • BAYZF - German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks | Benzinga

    Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a seri...

  • BAYZF - Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence | Benzinga

    Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study early after asundexian showed inferiority to&nb...

  • BAYZF - Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details | Benzinga

    Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study investigating asundexian compared to apixaban (a direct oral...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

Market Wire News App

Sign up for the Market Wire News App now!

The Market Wire news app is set to launch soon, be one of the first to try it out before it's in the store.


Be alerted of any news about your stocks and see what other stocks are trending.

Market Wire News App

Sign up for the Market Wire News App now!

The Market Wire news app is set to launch soon, be one of the first to try it out before it's in the store.


Be alerted of any news about your stocks and see what other stocks are trending.

Get BAYZF Alerts

Get BAYZF Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| Google News

| X

| Facebook

| LinkedIn

| Telegram

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2023 Market Wire News